- info@myglp1store.com
- +1 (904) 942-2327
- 6953 Powers avenue suite 19 Jacksonville Fl 32217
Need Any Help?
+1 (904) 942-2327
+1 (904) 942-2327
Price range: $119.00 through $1,142.40
Mazdutide is an investigational synthetic dual-agonist peptide supplied exclusively for laboratory and in-vitro research involving GLP-1 and GIP receptor signaling pathways. This compound is intended strictly for experimental research use only and is not approved for human or veterinary applications.
Ingredients / Composition:
Active Compound: Mazdutide (synthetic dual-agonist peptide)
Net Peptide Content: 10 mg per vial
Form: Lyophilized peptide powder
Excipients: None added unless otherwise specified
Mazdutide has been studied in controlled scientific literature for its interaction with GLP-1 and GIP receptors, supporting investigations into receptor binding behavior, intracellular signaling pathways, and metabolic pathway modeling in experimental systems. All references to published studies are provided solely for scientific context and experimental design discussion, not for administration guidance or biological outcome expectations.
This product is intended for research purposes only. It is designated strictly for in vitro testing and laboratory experimentation and is not approved for human or animal consumption. All information provided on this website is for educational and informational purposes only. This product should be handled only by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Mazdutide is a synthetic peptide investigated for its dual activity at glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.
This dual-receptor profile enables researchers to examine coordinated incretin pathway signaling and downstream cellular responses within controlled experimental systems.
In laboratory research settings, Mazdutide may be incorporated into studies evaluating:
Ligand-receptor binding kinetics
Signal transduction cascades associated with incretin pathways
Comparative dual-agonist peptide performance
Cellular metabolism response modeling
Compound stability and degradation behavior
Its molecular structure allows for investigation into how simultaneous receptor engagement influences intracellular communication pathways and metabolic signaling networks.
Mazdutide may support experimental protocols involving:
Receptor affinity and activation assays
Second-messenger response measurements
Peptide structure-activity relationship studies
In-vitro metabolic pathway simulations
Controlled pharmacodynamic research models
Researchers can use this compound to explore mechanistic hypotheses regarding incretin receptor interactions and coordinated pathway modulation under defined laboratory conditions.
Compound: Mazdutide (Research Grade)
Net Content: 10 mg per vial
Form: Lyophilized peptide powder
Analytical Verification: Identity and purity confirmed via laboratory testing methods such as HPLC and mass spectrometry where applicable
Storage: Maintain under laboratory-appropriate cold storage conditions
Each vial is prepared for accurate laboratory measurement and experimental reproducibility across research protocols.
This product is sold strictly for research and laboratory use only.
Not intended for:
Human consumption
Animal use
Diagnostic procedures
Therapeutic development or clinical application
No physiological effects, medical outcomes, or performance results are implied or guaranteed. All handling, storage, and experimental use must comply with institutional policies, ethical review standards, and applicable regulatory frameworks.
Mazdutide is provided as an AntagonistĀ to support scientific investigation into incretin receptor mechanisms and metabolic signaling pathways.
Mazdutide is an investigational synthetic dual-agonist peptide supplied exclusively for laboratory and in-vitro research involving GLP-1 and GIP receptor signaling pathways. This compound is intended strictly for experimental research use only and is not approved for human or veterinary applications.
Ingredients / Composition:
Active Compound: Mazdutide (synthetic dual-agonist peptide)
Net Peptide Content: 10 mg per vial
Form: Lyophilized peptide powder
Excipients: None added unless otherwise specified
Mazdutide has been studied in controlled scientific literature for its interaction with GLP-1 and GIP receptors, supporting investigations into receptor binding behavior, intracellular signaling pathways, and metabolic pathway modeling in experimental systems. All references to published studies are provided solely for scientific context and experimental design discussion, not for administration guidance or biological outcome expectations.
Reviews
There are no reviews yet.